Tag: Abbott
Remote monitoring improves survival in heart failure patients analysis finds
Abbott has today announced new data that found monitoring patients remotely with haemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can...
Healthy or hazardous: Study raises “red flag” on wearable smart device...
A new “red flag-raising” study has provided benchmark data on the safety of smart scales, watches and rings with bioimpedance technology for patients with...
Abbott to receive multiple CES 2023 awards for neurostimulation and pacemaker...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...
FDA approval for Abbott’s Aveir VR leadless pacemaker
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage...
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indication for the company’s CardioMEMS HF system to support...
Abbott receives US FDA approval for Gallant ICD and CRT-D devices
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation...
Abbott receives CE mark approval for Gallant ICD and CRT-D devices
Abbott has announced that it has received CE mark approval for the Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices.
The...
Confirm Rx ICM allies with SharpSense technology and syncs to a...
Disclaimer: Advertorial sponsored by Abbott
Launched in May 2019 by Abbott, the next-generation Confirm Rx™ insertable cardiac monitor (ICM) has both the CE Mark in...
First US clinical study to assess ablation for monomorphic ventricular ablation...
Abbott has announced the start of LESS-VT—the first US clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic...
US FDA approve HeartMate 3 heart pump advanced heart failure patients...
The HeartMate 3 left ventricular assist device has received US FDA approval as a destination therapy for people living with advanced heart failure. With...
Case report: Mapping a complex macroreentrant atrial arrhythmia in congenital heart...
This article has been sponsored by Abbott
Case description
A 31 year-old female with tricuspid atresia and normally related great vessels who underwent an atriopulmonary Fontan...
HeartMate 3 left ventricular assist system: Class I recall
The US FDA has issued a class I recall due to a malfunction in the device’s outflow graft assembly that may cause the outflow...
Battery performance alert and cybersecurity firmware updates for certain Abbott implantable...
The US FDA has approved a firmware update that is now available and is intended as a corrective action (recall), to reduce the risk...
New long-term data show improved survival and lower rates of stroke...
New late-breaking clinical trial data from the MOMENTUM 3 clinical study shows overall survival of 83% at 2-years and marked improvement in clinical outcomes for...
New FDA approvals for Abbott’s MRI-ready devices
Abbott has announced the US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for the Quadra Assura MP cardiac resynchronisation therapy...
Confirm Rx ICM: Convenient. Connected. Continuous.
This video has been sponsored by Abbott.
The Confirm Rx implantable cardiac monitor (ICM) is the world’s first and only insertable cardiac monitor that combines...
Northwestern Medicine implement first LVAD with MagLev pump
In Illinois, USA, Jesus Garcia has become the first patient in his state to receive the HeartMate 3 (Abbott/St. Jude Medical) left ventricular assist...
Smartphone compatible ICM launches in USA
The US Food and Drug Administration (FDA) has approved Abbott St. Jude Medical’s Confirm Rx insertable cardiac monitor (ICM), a smartphone compatible ICM designed to...
FDA approval for MRI-compatibility for Ellipse ICD
Abbott has received US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for one of the company’s most widely-used implantable cardioverter...
Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval
The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...
US trial to evaluate safety and efficacy of Amplatzer for patent...
Abbott has initiated a US pivotal clinical study evaluating the safety and effectiveness of a modified version of its Amplatzer device to correct patent...
Abbott receives CE mark for its Confirm Rx insertable cardiac monitor...
Abbott has announced CE mark and first use of the new Confirm Rx ICM. According to a company release, this is the world’s first smartphone...
ACC 2017: Real-world study supports the effectiveness of the CardioMEMS HF...
A study outside the clinical trial setting, which included US Medicare patients, has shown the effectiveness of the CardioMEMS HF system (Abbott) to significantly...
US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled
The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter.
The Sensor Enabled...
US FDA approves Assurity MRI pacemaker
Abbott has announced US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for both the Assurity MRI pacemaker and the Tendril...
Abbott completes the acquisition of St Jude Medical
Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...
New alliance for heart failure calls for improved care for condition
A coalition of charities, patient groups, professional bodies and healthcare companies with an interest in heart failure has been established to raise the profile...